High materiality7/10
Cytokinetics price target raised to $112 from $106 at Truist Financial
Why it may matterVerify against the original reporting
Further upside potential.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist Financial raises CYTK price target to $112 from $106; current price is $76.45.
- PT raised to $112 from $106; price now $76.45.
Key facts
- 01
Target: $112
- 02
Posted price: $76.45
- 03
Analyst firm: Truist Financial
- 04
Analyst: Srikripa Devarakonda
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.